Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 15;95(1):e13108. doi: 10.1111/sji.13108

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Scandinavian Foundation for Immunology

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

PMC Copyright notice

Flow cytometric analysis of MDSCs from (a) a control, (b) a patient in the mild subgroup and (c) a patient in the severe subgroup. Total MDSCs were identified as HLA‐DR^‐CD11b⁺ on the myeloid gate. PMN‐MDSCs were determined as CD15⁺CD66b⁺ population (R1 gate) and classified as CD16⁺ mature and immature PMN‐MDSCs. M‐MDSCs were determined as CD14⁺ population in the CD15^‐CD66b^‐ population (R2 gate). M‐MDSCs, monocytic myeloid‐derived suppressor cells; MDSCs, Myeloid‐derived suppressor cells; PMN‐MDSCs, polymorphonuclear myeloid‐derived suppressor cells